LONDON, ONTARIO--(Marketwire - November 14, 2008) - Critical Outcome Technologies Inc. (TSX VENTURE: COT), announced today the Company will meet with several prospective partners for its lead oncology drug candidate COTI-2 at BIO Europe 2008 taking place November 17-19 in Manheim, Germany.
